GNH USA

Europe — EMA

Minreksav (Cytisinicline)

GNH USA supplies Minreksav (Cytisinicline), a partial agonist of nicotinic acetylcholine receptors for smoking cessation. Request a quote for global supply.

Cytisinicline

Request sourcing

1
Pack/s

What is Cytisinicline?

Cytisinicline, the active ingredient in Minreksav, is a partial agonist of nicotinic acetylcholine receptors presented as an oral tablet for oral use. It helps adult smokers reduce nicotine cravings and manage withdrawal symptoms during cessation attempts. It is intended for use under medical supervision.

GNH USA supplies Minreksav as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory documentation for global distribution. GNH USA also offers logistics support, including temperature‑controlled shipping where required.

What is Cytisinicline used for?

Minreksav acts on nicotinic acetylcholine receptors to aid smoking cessation.

Smoking cessation: Reduces nicotine cravings and alleviates withdrawal symptoms, supporting adults who wish to quit smoking.

What are the side effects of Cytisinicline?

Cytisinicline may be associated with several adverse reactions, which are categorized by frequency and severity.

Common Side Effects: - Nausea: mild to moderate stomach upset. - Headache: transient cranial pain. - Insomnia: difficulty falling or staying asleep. - Dry mouth: reduced salivation.

Serious or Rare Side Effects: - Mood changes: depression or anxiety worsening. - Cardiovascular events: chest pain or irregular heartbeat. - Severe allergic reaction: rash, swelling, or anaphylaxis.

What precautions apply to Cytisinicline?

When prescribing Cytisinicline, clinicians should observe several precautionary measures to ensure safe use. - Assess smoking history: confirm patient is an adult smoker seeking cessation. - Evaluate cardiovascular status: use caution in patients with heart disease. - Monitor psychiatric conditions: watch for mood alterations. - Avoid concurrent use with other nicotine replacement therapies unless advised. - Store below 25°C: keep in the original pack, protect from moisture.

What does Cytisinicline interact with?

Cytisinicline can interact with other medicines, requiring attention to avoid reduced efficacy or increased toxicity.

Major Interactions (Avoid): - Monoamine oxidase inhibitors (MAOIs): may amplify cardiovascular effects. - Strong CYP2D6 inhibitors: can increase Cytisinicline plasma levels.

Moderate Interactions (Monitor Closely): - Other nicotine replacement products: may lead to additive nicotinic stimulation. - Antidepressants affecting serotonin: possible mood alterations. - Alcohol: may enhance dizziness or sedation.

Frequently asked questions

What is Minreksav used for?+
Minreksav is prescribed to help adult patients who smoke quit by reducing nicotine cravings and easing withdrawal symptoms. It belongs to the class of smoking cessation therapies that target nicotinic acetylcholine receptors, supporting a smoother transition away from tobacco use.
How does Cytisinicline work?+
Cytisinicline acts as a partial agonist at the α4β2 subtype of neuronal nicotinic acetylcholine receptors. It delivers a modest stimulatory signal that mimics nicotine, lowering cravings, while simultaneously blocking nicotine from fully activating the receptors, which diminishes the rewarding effect of smoking.
What is the usual dose of Minreksav?+
The specific dose of Minreksav is determined by the prescribing healthcare professional based on the individual’s medical condition, smoking history, and response to therapy. Patients should follow the prescriber’s instructions and not alter the dose without medical advice.
Is Minreksav safe during pregnancy or breastfeeding?+
Safety data for Cytisinicline in pregnancy and lactation are limited. It should only be used if the potential benefit justifies any potential risk to the fetus or infant. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss alternatives with their healthcare provider.
How do I order Minreksav from GNH USA?+
To request Minreksav, submit an enquiry on the product page at gnh-usa.com, specifying the required quantity. GNH USA supplies hospitals, pharmacies and procurement teams worldwide, and will verify trade or institutional credentials before providing pricing, availability, shipping details and any necessary import documentation.
How does Minreksav compare with other smoking‑cessation drugs?+
Minreksav’s active ingredient, Cytisinicline, is a partial agonist of nicotinic receptors, similar to varenicline but with a distinct binding profile that may result in different tolerability. Both aim to reduce cravings, yet individual response and side‑effect patterns can vary, making physician assessment essential for choosing the most suitable option.
What are the storage and handling requirements for Minreksav?+
Minreksav should be stored below 25 °C in its original packaging, protected from moisture and direct sunlight. Keep the product out of reach of children and avoid exposing it to extreme temperatures or humidity to maintain its stability and efficacy.
How is Minreksav administered?+
Minreksav is taken orally, typically as a tablet swallowed whole with water. It is usually taken at the same time each day, and patients should follow the dosing schedule prescribed by their healthcare professional to achieve optimal results.
What are the most serious risks associated with Minreksav?+
Serious risks include mood alterations such as worsening depression or anxiety, cardiovascular events like chest pain or irregular heartbeat, and severe allergic reactions that may present as rash, swelling or anaphylaxis. Patients should seek immediate medical attention if any of these symptoms occur.
Who should not use Minreksav?+
Minreksav is contraindicated in individuals with known hypersensitivity to Cytisinicline or any tablet excipients, in patients under 18 years of age, and in those with uncontrolled severe cardiovascular disease. Anyone with a history of serious psychiatric disorders should discuss suitability with a healthcare provider.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.
Send a sourcing enquiry for this product →

Product details

Drug
Cytisinicline
Route
Oral Use
Manufacturer
Apc Instytut Sp. Z O.O.
Origin
EU

Related products

Asmoken

Asmoken

Cytisinicline

Aflofarm Farmacja Polska Sp. Z O.O.
EU
Asmoken

Asmoken

Cytisinicline

Aflofarm Farmacja Polska Sp. Z O.O.
EU
Asmoken

Asmoken

Cytisinicline

Aflofarm Farmacja Polska Sp. Z O.O.
EU
Belnifrem

Belnifrem

Cytisinicline

Adamed Pharma S.A.
EU